Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Barnum

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Journal of Neuroinflammation|January 18, 2012
Psychological stress in adolescent and adult mice increases neuroinflammation and attenuates the response to LPS challengeChristopher J Barnum, Thaddeus W W Pace, Fang Hu, et al.
Synapse (New York, N.Y.)|March 25, 2009
The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian ratsKaren L Eskow, Kristin B Dupre, Christopher J Barnum, et al.
Physiology & Behavior|March 17, 2011
Stress-dependent changes in neuroinflammatory markers observed after common laboratory stressors are not seen following acute social defeat of the Sprague Dawley ratCara M Hueston, Christopher J Barnum, Jaime A Eberle, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 21, 2010
Delayed dominant-negative TNF gene therapy halts progressive loss of nigral dopaminergic neurons in a rat model of Parkinson's diseaseAshley S Harms, Christopher J Barnum, Kelly A Ruhn, et al.
Brain Research Bulletin|January 11, 2005
Stress-induced increases in hypothalamic IL-1: a systematic analysis of multiple stressor paradigmsTerrence Deak, Kelly A Bordner, Nevin K McElderry, et al.
Journal of Parkinson'S Disease|July 26, 2014
Peripheral administration of the selective inhibitor of soluble tumor necrosis factor (TNF) XPro®1595 attenuates nigral cell loss and glial activation in 6-OHDA hemiparkinsonian ratsChristopher J Barnum, Xi Chen, Jaegwon Chung, et al.
Journal of Neuroscience Research|December 31, 2008
Contribution of the striatum to the effects of 5-HT1A receptor stimulation in L-DOPA-treated hemiparkinsonian ratsChristopher Bishop, David M Krolewski, Karen L Eskow, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 16, 2011
Behavioral and cellular modulation of L-DOPA-induced dyskinesia by beta-adrenoceptor blockade in the 6-hydroxydopamine-lesioned ratDavid Lindenbach, Corinne Y Ostock, Karen L Eskow Jaunarajs, et al.
Magnetic Resonance Imaging|August 3, 2014
Simultaneous imaging of locus coeruleus and substantia nigra with a quantitative neuromelanin MRI approachXiangchuan Chen, Daniel E Huddleston, Jason Langley, et al.
Pharmacology, Biochemistry, and Behavior|October 8, 2011
Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian ratsChristopher J Barnum, Nirmal Bhide, David Lindenbach, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Neuroinflammation|January 18, 2012
Psychological stress in adolescent and adult mice increases neuroinflammation and attenuates the response to LPS challengeChristopher J Barnum, Thaddeus W W Pace, Fang Hu, et al.
Synapse (New York, N.Y.)|March 25, 2009
The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian ratsKaren L Eskow, Kristin B Dupre, Christopher J Barnum, et al.
Physiology & Behavior|March 17, 2011
Stress-dependent changes in neuroinflammatory markers observed after common laboratory stressors are not seen following acute social defeat of the Sprague Dawley ratCara M Hueston, Christopher J Barnum, Jaime A Eberle, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 21, 2010
Delayed dominant-negative TNF gene therapy halts progressive loss of nigral dopaminergic neurons in a rat model of Parkinson's diseaseAshley S Harms, Christopher J Barnum, Kelly A Ruhn, et al.
Brain Research Bulletin|January 11, 2005
Stress-induced increases in hypothalamic IL-1: a systematic analysis of multiple stressor paradigmsTerrence Deak, Kelly A Bordner, Nevin K McElderry, et al.
Journal of Parkinson'S Disease|July 26, 2014
Peripheral administration of the selective inhibitor of soluble tumor necrosis factor (TNF) XPro®1595 attenuates nigral cell loss and glial activation in 6-OHDA hemiparkinsonian ratsChristopher J Barnum, Xi Chen, Jaegwon Chung, et al.
Journal of Neuroscience Research|December 31, 2008
Contribution of the striatum to the effects of 5-HT1A receptor stimulation in L-DOPA-treated hemiparkinsonian ratsChristopher Bishop, David M Krolewski, Karen L Eskow, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 16, 2011
Behavioral and cellular modulation of L-DOPA-induced dyskinesia by beta-adrenoceptor blockade in the 6-hydroxydopamine-lesioned ratDavid Lindenbach, Corinne Y Ostock, Karen L Eskow Jaunarajs, et al.
Magnetic Resonance Imaging|August 3, 2014
Simultaneous imaging of locus coeruleus and substantia nigra with a quantitative neuromelanin MRI approachXiangchuan Chen, Daniel E Huddleston, Jason Langley, et al.
Pharmacology, Biochemistry, and Behavior|October 8, 2011
Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian ratsChristopher J Barnum, Nirmal Bhide, David Lindenbach, et al.
Pageof 3